HKD 0.12
(-14.71%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -7.39 Million HKD | 76.62% |
2022 | -8.98 Million HKD | -13.42% |
2021 | -6.05 Million HKD | 83.05% |
2020 | -104.06 Million HKD | 31.6% |
2019 | -135.55 Million HKD | -12.96% |
2018 | -115.59 Million HKD | -35.26% |
2017 | -88.53 Million HKD | -10.21% |
2016 | -30.42 Million HKD | -141.09% |
2015 | -33.22 Million HKD | 0.0% |
2013 | -743 Thousand HKD | 95.02% |
2012 | -18.24 Million HKD | -111.46% |
2011 | -99.74 Million HKD | 2127.31% |
2010 | -180.75 Million HKD | -118.75% |
2009 | 39.02 Million HKD | 207.78% |
2008 | 12.68 Million HKD | 326.36% |
2007 | 2.97 Million HKD | 257.93% |
2006 | -1.88 Million HKD | 40.17% |
2005 | -3.14 Million HKD | 22.17% |
2004 | -4.04 Million HKD | -31.25% |
2003 | -3.08 Million HKD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -1.55 Million HKD | 64.31% |
2024 Q2 | -1.55 Million HKD | 0.0% |
2023 Q2 | -5.94 Million HKD | -409.43% |
2023 Q4 | 5.41 Million HKD | 50.71% |
2023 Q1 | -1.16 Million HKD | -130.2% |
2023 Q3 | 3.59 Million HKD | 160.47% |
2023 FY | - HKD | 76.62% |
2022 Q3 | -5.03 Million HKD | -3148.48% |
2022 Q4 | 3.86 Million HKD | 176.82% |
2022 Q1 | -8.76 Million HKD | -117.51% |
2022 Q2 | 165 Thousand HKD | 101.88% |
2022 FY | - HKD | -13.42% |
2021 Q2 | -31.25 Million HKD | -80.82% |
2021 Q1 | -17.28 Million HKD | 68.76% |
2021 Q3 | -13.03 Million HKD | 58.29% |
2021 Q4 | 50.05 Million HKD | 483.89% |
2021 FY | - HKD | 83.05% |
2020 Q1 | -20.72 Million HKD | 78.13% |
2020 Q3 | -15.04 Million HKD | 43.02% |
2020 Q4 | -55.33 Million HKD | -267.87% |
2020 FY | - HKD | 31.6% |
2020 Q2 | -26.39 Million HKD | -27.4% |
2019 FY | - HKD | -12.96% |
2019 Q4 | -94.74 Million HKD | -512.66% |
2019 Q3 | -15.46 Million HKD | 41.14% |
2019 Q1 | -23.52 Million HKD | 48.25% |
2019 Q2 | -26.27 Million HKD | -11.67% |
2018 FY | - HKD | -35.26% |
2018 Q2 | -24.38 Million HKD | -24.21% |
2018 Q3 | -43.41 Million HKD | -78.06% |
2018 Q4 | -45.46 Million HKD | -4.73% |
2018 Q1 | -19.62 Million HKD | 42.22% |
2017 Q3 | -34.67 Million HKD | -232.23% |
2017 Q1 | -21.08 Million HKD | 33.99% |
2017 FY | - HKD | -10.21% |
2017 Q4 | -33.97 Million HKD | 2.02% |
2017 Q2 | -10.43 Million HKD | 50.5% |
2016 Q1 | -22.73 Million HKD | -5.74% |
2016 Q2 | -14.93 Million HKD | 34.3% |
2016 Q3 | -20.86 Million HKD | -39.65% |
2016 Q4 | -31.94 Million HKD | -53.11% |
2016 FY | - HKD | -141.09% |
2015 FY | - HKD | 0.0% |
2015 Q2 | -4.33 Million HKD | -73.4% |
2015 Q1 | -2.5 Million HKD | 0.0% |
2015 Q3 | -9.54 Million HKD | -120.21% |
2015 Q4 | -21.5 Million HKD | -125.28% |
2014 Q2 | -3.79 Million HKD | -596.88% |
2014 Q3 | 87 Thousand HKD | 102.29% |
2014 Q1 | -545 Thousand HKD | -26.74% |
2013 Q4 | -430 Thousand HKD | -135.74% |
2013 FY | - HKD | 95.02% |
2013 Q1 | -6.57 Million HKD | 5.42% |
2013 Q3 | 1.2 Million HKD | 1895.52% |
2013 Q2 | -67 Thousand HKD | 98.98% |
2012 Q1 | -9.19 Million HKD | -754.55% |
2012 FY | - HKD | -111.46% |
2012 Q3 | -4.97 Million HKD | -103.3% |
2012 Q2 | 150.77 Million HKD | 1739.75% |
2012 Q4 | -6.95 Million HKD | -39.7% |
2011 Q3 | 154.61 Million HKD | 186.82% |
2011 Q2 | -178.08 Million HKD | -3455.24% |
2011 Q1 | -5 Million HKD | -1888.93% |
2011 FY | - HKD | 2127.31% |
2011 Q4 | -1.07 Million HKD | -100.7% |
2010 Q4 | 280 Thousand HKD | -93.3% |
2010 Q1 | 5.16 Million HKD | -64.0% |
2010 Q2 | 16.14 Million HKD | 212.63% |
2010 Q3 | 4.18 Million HKD | -74.11% |
2010 FY | - HKD | -118.75% |
2009 Q3 | 1.87 Million HKD | -61.22% |
2009 Q1 | 2.9 Million HKD | 20.24% |
2009 FY | - HKD | 207.78% |
2009 Q4 | 14.34 Million HKD | 663.9% |
2009 Q2 | 4.84 Million HKD | 66.7% |
2008 FY | - HKD | 326.36% |
2008 Q4 | 2.41 Million HKD | 93.28% |
2008 Q3 | 1.25 Million HKD | 0.0% |
2007 FY | - HKD | 257.93% |
2006 FY | - HKD | 40.17% |
2005 FY | - HKD | 22.17% |
2004 FY | - HKD | -31.25% |
2003 FY | - HKD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 22.91 Million HKD | 132.293% |
Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | 102.329% |
China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | 464.662% |
Prosperous Future Holdings Limited | -19.68 Million HKD | 62.415% |
Huasheng International Holding Limited | 19.67 Million HKD | 137.6% |
Fourace Industries Group Holdings Limited | 61.52 Million HKD | 112.026% |
Evergreen Products Group Limited | 140.78 Million HKD | 105.256% |
EC Healthcare | 737.83 Million HKD | 101.003% |
Ming Fai International Holdings Limited | 211.83 Million HKD | 103.493% |
Blue Moon Group Holdings Limited | 656.37 Million HKD | 101.127% |
Takbo Group Holdings Limited | 25.8 Million HKD | 128.674% |
Hyfusin Group Holdings Limited | 154.18 Million HKD | 104.799% |